Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Nutrition & Diabetes|November 11, 2024
Abnormal changes of brain function and structure in patients with T2DM-related cognitive impairment: a neuroimaging meta-analysis and an independent validationPan Dai, Ying Yu, Qian Sun, et al.
Clinical Genetics|July 26, 2022
Identification of novel rare copy number variants associated with sporadic tetralogy of Fallot and clinical implicationsGuo-Wei He, Cheryl L Maslen, Huan-Xin Chen, et al.
BMC Medical Imaging|April 8, 2025
Habitat analysis of iron deposition in the basal ganglia for diagnosing cognitive impairment in chronic kidney disease: evidence from a case-control studyHao Wang, Yu Qi, Xu Liu, et al.
Brain Research Bulletin|January 6, 2026
Diagnosis of cognitive impairment in chronic kidney disease: A radiomics and machine learning approach with quantitative susceptibility mappingYi-Fan Guo, Yuan-Zhe Li, Yu Qi, et al.
Diabetology & Metabolic Syndrome|November 14, 2025
Temporal dynamic of cognitive decline in type 2 diabetes mellitus patients: a multimodal biomarker analysis using event-based modal and principal component analysisMin-Hua Ni, Bo Hu, Xiao-Yan Bai, et al.
Diabetes Research and Clinical Practice|April 15, 2025
Neurovascular decoupling of frontoparietal cortex-putamen-cerebellum network in type 2 diabetes patient: Potential biomarker for abnormal eating patternsYing Yu, Bo Hu, Xin-Wen Yu, et al.
Brain Research Bulletin|March 20, 2025
Dysregulated brain dynamics in the visualmotor network in type 2 diabetes patients and their relationship with cognitive impairmentYing Yu, Bo Hu, Xin-Wen Yu, et al.
Oncotarget|August 18, 2016
Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterationsNa-Na Lou, Xu-Chao Zhang, Hua-Jun Chen, et al.
Ebiomedicine|April 28, 2019
Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trialYi-Chen Zhang, Zhi-Hong Chen, Xu-Chao Zhang, et al.
Biomarker Research|July 23, 2025
Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective studyChang Lu, Chong-Rui Xu, Yi-Chen Zhang, et al.
Pageof 6